# A Study of Plasma-Derived Human Butyrylcholinesterase Administered Intramuscularly

> **NCT00333528** · PHASE1 · COMPLETED · sponsor: **Baxalta now part of Shire** · enrollment: 8 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Human butyrylcholinesterase (HuBChE) derived from human plasma
- **DRUG:** Placebo: Normal saline

## Key facts

- **NCT ID:** NCT00333528
- **Lead sponsor:** Baxalta now part of Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12-01
- **Primary completion:** 2008-04-01
- **Final completion:** 2008-08-01
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2021-05-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00333528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00333528, "A Study of Plasma-Derived Human Butyrylcholinesterase Administered Intramuscularly". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00333528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*